Skip to content

Search

Search managers or tickers

Engaged Capital

Q1 2019 13F · by Glenn Welling, CIO

As of
Mar 31, 2019
Filed
May 15, 2019
US stock
$712M · prev $539M
Positions
12 · prev 15
Options notional
$0
Documents
1· no amendments

Picture100.0% US stock

Full picture · of what this 13F reports is US stock

  • US stock listed on a US exchange 100.0%
  • Foreign stock not listed in the US 0.0%
  • Notes debt, at principal 0.0%
  • Puts at notional value 0.0%
  • Calls at notional value 0.0%

Moves10 since the prior filing

The book

Very concentrated · behaves like 3 equal-sized positions

  1. Very concentrated
  2. Concentrated
  3. Focused
  4. Diversified

Moderate turnover · 45% a year, about 2.2 years per position

  1. Low
  2. Moderate
  3. High

Top 5 positions88% of US stock

  1. HAIN Hain Celestial Group Inc added+20.13 pp added+20.1354.7%
  2. UPBD Upbound Group, Inc. held held15.6%
  3. APOG Apogee Enterprises Inc held held8.9%
  4. STKL SunOpta, Inc. added−0.68 pp added−0.684.2%
  5. VYX NCR Voyix Corporation held held4.1%

Positions12 in this filing · 4 exited

HAINHain Celestial Group Inc54.72%16,861,212$390Madded+43%+20.13 pp9 q
UPBDUpbound Group, Inc.15.62%5,333,609$111Mheld—10 q
APOGApogee Enterprises Inc8.89%1,689,332$63Mheld—6 q
STKLSunOpta, Inc.4.24%8,731,907$30Madded+27%−0.68 pp12 q
VYXNCR Voyix Corporation4.12%1,076,463$29Mheld—7 q
TIVOTivo Inc3.30%2,525,000$24Mheld—11 q
DFRGDel Frisco's Restaurant Group, Inc.2.99%3,328,000$21Mheld—2 q
MGLNMagellan Health Services, Inc.2.11%227,558$15Mtrimmed−11%−0.59 pp2 q
INWKInnerWorkings, Inc.1.31%2,582,346$9Mheld—3 q
BHEBenchmark Electronics1.27%343,873$9Mtrimmed−85%−7.51 pp17 q
PETXAratana Therapeutics, Inc.1.22%2,417,149$9Mtrimmed−31%−2.74 pp5 q
MEDMedifast, Inc.0.20%11,242$1Mnew+0.20 ppnew
ANIKAnika Therapeutics Inc—−374,926—exited−2.34 pp—
GRPNGroupon, Inc.—−2,445,406—exited−1.45 pp—
ASTEAstec Industries Inc—−73,605—exited−0.41 pp—
BWBabcock & Wilcox Enterprises, Inc.—−3,774,724—exited−0.27 pp—

Source

Form
13F-HR
Reading
0 defects · 0 unresolved
Options
none in this filing
Notes
none in this filing
SEC cross-check
SEC data set not published yet